Expanded AVIEW portfolio spans lung and cardiovascular analysis, supported by 13 U.S. FDA 510(k) clearances Drawing on lung cancer screening experience across Germany, France, and Italy to highlight the shift from AI detection to real-world clinical implementation CHICAGO and SEOUL, South…



